Mixed
An intensive weight loss intervention combining total diet replacement (800-850 kcal/day), behavioral support, and weight loss medication achieves and maintains >20% weight loss and improves cardiometabolic risk in adults with severe obesity (BMI ≥35 kg/m²) over 2 years.
For severe obesity, standard 'eat less, move more' advice often fails. This protocol uses a 2-year structured approach: start with a very low-calorie formula diet (800-850 kcal) for 12 weeks with weekly support. If you don't lose enough weight, add a GLP-1 medication. Then, gradually transition to a healthy, low-calorie diet while maintaining exercise. The key is the intensive support and the ability to 'rescue' the plan with formula meals or medication if you regain weight.
The IWL intervention aims to support participants to achieve and maintain a weight loss of at least 20% from baseline or a BMI <25 kg/m2... The experimental group will be offered a 2- year intensive weight loss programme providing support and advice to follow a total diet replacement programme, followed by gradual transition to an energy- reduced diet in combination with increased physical activity and if needed, prescription of weight loss medication.
Why this rating
This is a trial protocol; no results are reported yet. The evidence rating reflects the study design (randomized controlled trial) which is high quality, but the lack of results means the claim is currently a hypothesis.
Source
Intensive weight loss intervention versus usual care for adults with severe and complex obesity: the LightWAY randomised trial protocol
Sarah Wane et al. · BMJ Open · 2026
DOI 10.1136/bmjopen-2025-107240
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →